Viewing Study NCT01746251


Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-02-25 @ 7:21 PM
Study NCT ID: NCT01746251
Status: UNKNOWN
Last Update Posted: 2020-07-07
First Post: 2012-11-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adjuvant Afatinib in Stage I-III NSCLC With EGFR Mutation
Sponsor: Massachusetts General Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Non Small Cell Lung Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None EGFR mutation View
None Resected View